Article
Moderna to reduce COVID-19 vaccine production at Lonza's Swiss facility
Rating:
0.0
Views:
35
Likes:
1
Library:
1
Moderna has revealed its intention to reduce the production of the mRNA drug substance used in its COVID-19 vaccine at Lonza's Swiss facility during this quarter.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value